What Is It For?
The Psychotropic test assesses the impact of your genetic composition on the effectiveness of medications typically prescribed for depression, anxiety, ADHD, and related mental health issues. It furnishes your clinician with insights into whether certain medications may necessitate dosage modifications, exhibit reduced efficacy, or pose a heightened risk of side effects due to your genetic profile.
Get Genetic Information For A Wide Variety of Psychotropic Medications
The results from Molecular PGx’s Psychotropic Pharmacogenetics Gene Variation Panel provide genetic insights and treatment recommendations for a diverse range of psychotropic medications, comprising: Amitriptyline, amoxapine, aripiprazole, aripiprazole lauroxil, atomoxetine, brexpiprazole, citalopram, clomipramine, clozapine, desipramine, diazepam, doxepin, duloxetine, escitalopram, fluvoxamine, iloperidone, imipramine, lofexidine, nortriptyline, paroxetine, perphenazine, protriptyline, risperidone, sertraline, thioridazine, trimipramine, venlafaxine, vortioxetine
Learn More